.
Here we describe the first human genetic defect in a component of the Arp2/3 complex itself. The Table 1 ). The mean platelet volume (MPV) was repeatedly found to be normal (mean of 8.8 fL, n=9 samples; normal range 7.4-11.7 fL).
His second admission was due to an auricular infection (perichondritis by S. aureus), which was treated appropriately, but resulted in scarring of his right pinnacle (Fig.1A) . At the age of 5 months, he presented again with a clinical picture of fever and purpuric lesions on his legs, arms ( platelet antigens, and lupus anti-coagulans (LAC), and found all tests to be negative (data not shown).
He suffered from two similar episodes of vasculitis in the presence of a high number of eosinophils (peaking at 3350 cells/μl at 25 months of age during an infection) that were treated with corticosteroids for 3 months each. His eosinophil counts remained within the normal range thereafter (Online Repository Table 1 ).
At the age of 4 years, he suffered from a period of prolonged bloody diarrhea from which Salmonella typhimurium was cultured due to a serious pan-colitis with neutrophil and eosinophil infiltration in the biopsies of his colon (Fig.1E) . Recurrent pneumonias that responded to antibiotics have led to mild bronchiectasis. Apart from infections he developed serious eczema and showed anaphylaxis after ingestion of nuts. The immunoglobulin spectrum shows increased IgA and IgE (Online Repository Table 1 ).
Because of the early leukocytosis and initial bleeding tendency, we excluded leukocyte adhesion defects, including LAD-III 6 . The most eminent in-vitro findings consisted of the neutrophil defect in motility and directed movement (chemotaxis) due to an F-actin polymerization defect ( Fig.3A) .
Also, detection of GpIIb/IIIa integrin activation and upregulation of CD62P and CD63 from the granules were tested and compared with control platelets similarly activated (Online Repository   Fig.3B ). Although spreading of patient platelets was different from control platelets (Online repository Fig.1B ) and CD62P and CD63 upregulation was slightly reduced, GpIIb/IIIa activation seemed intact. Clinically, the bleeding tendency is was not apparent anymore after these initial bleeding events during further follow-up in the presence of a mild thrombocytopenia.
Exome sequencing failed to pick up a mutation (because of the default 'variant caller' parameter settings in this complex genetic defect), but subsequent proteomics analysis of the platelets and neutrophils indicated a complete lack of ARPC1B ( Fig.2A-D) . ARPC1B is an essential hematopoietic component of the Arp2/3 complex for F-actin polymerization. The ARPC1B deficiency was caused by a homozygous complex frameshift mutation in the ARPC1B gene (c.491_495TCAAGdelCCTGCCCins), as confirmed by additional targeted sequencing approaches with improved, customized 'variant caller' parameter settings for the detection of complex mutations (Online Repository Fig.4) . The complex nature of the mutation in this family might be the consequence of a double strand break 4 (DSB) repaired by nonhomologous end joining (NHEJ), or by a microhomology-mediated end-joining mechanism (MMEJ) 8, 9 . Proteomics analysis demonstrated the presence of the Arp2/3 complex in normal neutrophils, T cells and platelets to consist of ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5 and ARPC5L, but absence of ARPC1A. Since ARPC1B was also expressed in tissue cells, the migration defect observed in neutrophils was expected to be present in primary fibroblasts as well. However, these cells showed normal migratory behavior and we may conclude that the non-hematopoietic expression of ARPC1A is apparently sufficient to rescue the fibroblasts from a detectable defect (Online Repository Fig.5) . Expression of ARPC1A and ARPC1B were variably present in additional non-hematopoietic cell lines (HeLa, SKBR3 and HEK273) indicating redundancy of ARPC1 proteins, while only ARPC1B protein was detected in hematopoietic cell lines (Daudi, Ramos, Jurkat, NB4, U937), similar to the various findings with fibroblasts versus blood cells tested (data not shown).
Together, these novel data on ARPC1 protein expression may well explain why this ARPC1B defect manifests primarily as an hematological and immunological disease.
When Arpc1b -/-mice (Arpc1b
tm1a(EUCOMM)Wtsi
) were generated and compared to the patient (Online Repository Table 2 ), no changes in whole blood cell counts were found. While serum total IgG, IgA and IgM levels were normal, total IgE level had increased at 16 weeks (0 ± 0 ng/ml in wild-type versus 220.6 ± 266.9 ng/ml in Arpc1b -/-mice). In 75% of the Arpc1b-deficient mice mild inflammation of the blood vessels was observed, targeting the aorta and/or the mesenteric and pancreatic arteries (Fig.2E ). Upon challenge with the attenuated S. typhimurium M525 and unlike their wild-type equivalents, Arpc1b -/-mice showed signs of salmonellosis by day 3 post-infection, with 5 out of 8 mice having to be sacrificed by day 5 (Fig.2F) . In contrast, wild-type mice all survived the challenge.
The fact that ARPC1B is the only ARPC1 isoform in hematopoietic cells, whereas both ARPC1A and ARPC1B are present in tissue cells, suggests a differential use of Arp2/3 activities in tissue and blood cells. Severe food allergies, eczema, and autoimmunity are also observed in WASP-and WIP-deficient patients causing Wiskott-Aldrich(-like) syndrome 3, 5, 10 , but this was genetically excluded in our patient. These immunodeficiencies tend to have a more severe bleeding tendency and more pronounced thrombocytopenia.
We have identified a novel combined immunodeficiency with features of recurrent infections, allergic reactions, vasculitis and mild bleeding tendency. The biology as well as the supportive evidence from the mouse model suggests a direct causal relationship between the ARPC1B mutation and the clinical manifestations. typhimurium M525.
